Human IFNAR2 deficiency: Lessons for antiviral immunity

Science Translational Medicine

Volumn 7, Issue 307, 2015, Pages

  Duncan, Christopher J A ^a,b   Mohamad, Siti M B ^a,c   Young, Dan F ^d   Skelton, Andrew J ^e   Leahy, T Ronan ^f   Munday, Diane C ^d   Butler, Karina M ^f   Morfopoulou, Sofia ^g   Brown, Julianne R ^h   Hubank, Mike ⁱ   Connell, Jeff ^j   Gavin, Patrick J ^f   McMahon, Cathy ^f   Dempsey, Eugene ^k   Lynch, Niamh E ^l   Jacques, Thomas S ⁱ   Valappil, Manoj ^m   Cant, Andrew J ^a,n   Breuer, Judith ^g,h   Engelhardt, Karin R ^a   Randall, Richard E ^d   Hambleton, Sophie ^a,n   more..

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

^d UNIVERSITY OF ST ANDREWS   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h GREAT ORMOND STREET HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY COLLEGE DUBLIN   (Ireland)

^k UNIVERSITY COLLEGE CORK   (Ireland)

^l BON SECOURS HOSPITAL   (Ireland)

^m PUBLIC HEALTH ENGLAND   (United Kingdom)

ⁿ Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; ALPHA INTERFERON; BETA INTERFERON; MEASLES MUMPS RUBELLA VACCINE; STAT2 PROTEIN; ANTIVIRUS AGENT; IFNAR2 PROTEIN, HUMAN; INTERFERON;

ANTIVIRAL IMMUNITY; ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; ENCEPHALITIS; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNITY; INFECTION SENSITIVITY; INOCULATION; MOUSE MODEL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEPTOR AFFINITY; SIBLING; VIRUS ATTENUATION; DEFICIENCY; FATALITY; GENETIC COMPLEMENTATION; INFANT; METABOLISM; RECESSIVE GENE; SIGNAL TRANSDUCTION;

ANTIVIRAL AGENTS; FATAL OUTCOME; GENES, RECESSIVE; GENETIC COMPLEMENTATION TEST; HUMANS; IMMUNITY; INFANT; INTERFERONS; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION;

EID: 84942843900     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aac4227     Document Type: Article

References (35)

1. L. C. Platanias, Mechanisms of type-I- And type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375-386 (2005).
2. D. B. Stetson, R. Medzhitov, Type I interferons in host defense. Immunity 25, 373-381 (2006).
3. A. Iwasaki, R. Medzhitov, Control of adaptive immunity by the innate immune system. Nat. Immunol. 16, 343-353 (2015).
4. R. E. Randall, S. Goodbourn, Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89, 1-47 (2008).
5. U. Müller, U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, M. Aguet, Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921 (1994).
6. J. E. Durbin, R. Hackenmiller, M. C. Simon, D. E. Levy, Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450 (1996).
7. M. A.Meraz, J.M.White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, R. D. Schreiber, Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442 (1996).
8. C. Park, S. Li, E. Cha, C. Schindler, Immune response in Stat2 knockout mice. Immunity 13, 795-804 (2000).
9. D. E. Levy, I. J. Marié, J. E. Durbin, Induction and function of type I and III interferon in response to viral infection. Curr. Opin. Virol. 1, 476-486 (2011).
10. G. Antonelli, C. Scagnolari, F. Moschella, E. Proietti, Twenty-five years of type I interferonbased treatment: A critical analysis of its therapeutic use. Cytokine Growth Factor Rev. 26, 121-131 (2014).
11. S. Dupuis, E. Jouanguy, S. Al-Hajjar, C. Fieschi, I. Z. Al-Mohsen, S. Al-Jumaah, K. Yang, A. Chapgier, C. Eidenschenk, P. Eid, A. Al Ghonaium, H. Tufenkeji, H. Frayha, S. Al-Gazlan, H. Al-Rayes, R. D. Schreiber, I. Gresser, J. L. Casanova, Impaired response to interferon-a/b and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33, 388-391 (2003).
12. Y. Minegishi, M. Saito, T. Morio, K. Watanabe, K. Agematsu, S. Tsuchiya, H. Takada, T. Hara, N. Kawamura, T. Ariga, H. Kaneko, N. Kondo, I. Tsuge, A. Yachie, Y. Sakiyama, T. Iwata, F. Bessho, T. Ohishi, K. Joh, K. Imai, K. Kogawa, M. Shinohara, M. Fujieda, H. Wakiguchi, S. Pasic, M. Abinun, H. D. Ochs, E. D. Renner, A. Jansson, B. H. Belohradsky, A. Metin, N. Shimizu, S. Mizutani, T. Miyawaki, S. Nonoyama, H. Karasuyama, Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25, 745-755 (2006).
13. S. Hambleton, S. Goodbourn, D. F. Young, P. Dickinson, S. M. Mohamad, M. Valappil, N. McGovern, A. J. Cant, S. J. Hackett, P. Ghazal, N. V. Morgan, R. E. Randall, STAT2 deficiency and susceptibility to viral illness in humans. Proc. Natl. Acad. Sci. U.S.A. 110, 3053-3058 (2013).
14. B. He, R. G. Paterson, N. Stock, J. E. Durbin, R. K. Durbin, S. Goodbourn, R. E. Randall, R. A. Lamb, Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: The multifunctional V protein blocks both interferon-b induction and interferon signaling. Virology 303, 15-32 (2002).
15. F. Weber, A. Bridgen, J. K. Fazakerley, H. Streitenfeld, N. Kessler, R. E. Randall, R. M. Elliott, Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J. Virol. 76, 7949-7955 (2002).
16. N. A. de Weerd, S. A. Samarajiwa, P. J. Hertzog, Type I interferon receptors: Biochemistry and biological functions. J. Biol. Chem. 282, 20053-20057 (2007).
17. B. Cohen, D. Novick, S. Barak, M. Rubinstein, Ligand-induced association of the type I interferon receptor components. Mol. Cell. Biol. 15, 4208-4214 (1995).
18. G. Lutfalla, S. J. Holland, E. Cinato, D. Monneron, J. Reboul, N. C. Rogers, J. M. Smith, G. R. Stark, K. Gardiner, K. E. Mogensen, I. M. Kerr, G. Uzé, Mutant U5A cells are complemented by an interferon-ab receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J. 14, 5100-5108 (1995).
19. J. A. Hill, N. Venna, Human herpesvirus 6 and the nervous system. Handb. Clin. Neurol. 123, 327-355 (2014).
20. K. Labska, K. Roubalova, D. Picha, V. Maresova, Presence of herpesvirus DNA in cerebrospinal fluid of patients with tick-borne encephalitis and enteroviral meningoencephalitis. J. Med. Virol. 87, 1235-1240 (2015).
21. A. Casrouge, S. Y. Zhang, C. Eidenschenk, E. Jouanguy, A. Puel, K. Yang, A. Alcais, C. Picard, N. Mahfoufi, N. Nicolas, L. Lorenzo, S. Plancoulaine, B. Sénéchal, F. Geissmann, K. Tabeta, K. Hoebe, X. Du, R. L. Miller, B. Héron, C. Mignot, T. B. de Villemeur, P. Lebon, O. Dulac, F. Rozenberg, B. Beutler, M. Tardieu, L. Abel, J. L. Casanova, Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314, 308-312 (2006).
22. S. Y. Zhang, E. Jouanguy, S. Ugolini, A. Smahi, G. Elain, P. Romero, D. Segal, V. Sancho-Shimizu, L. Lorenzo, A. Puel, C. Picard, A. Chapgier, S. Plancoulaine, M. Titeux, C. Cognet, H. von Bernuth, C. L. Ku, A. Casrouge, X. X. Zhang, L. Barreiro, J. Leonard, C. Hamilton, P. Lebon, B. Héron, L. Vallée, L. Quintana-Murci, A. Hovnanian, F. Rozenberg, E. Vivier, F. Geissmann, M. Tardieu, L. Abel, J. L. Casanova, TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522-1527 (2007).
23. F. G. Lafaille, I. M. Pessach, S. Y. Zhang, M. J. Ciancanelli, M. Herman, A. Abhyankar, S. W. Ying, S. Keros, P. A. Goldstein, G. Mostoslavsky, J. Ordovas-Montanes, E. Jouanguy, S. Plancoulaine, E. Tu, Y. Elkabetz, S. Al-Muhsen, M. Tardieu, T. M. Schlaeger, G. Q. Daley, L. Abel, J. L. Casanova, L. Studer, L. D. Notarangelo, Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491, 769-773 (2012).
24. C. Picard, A. Puel, M. Bonnet, C. L. Ku, J. Bustamante, K. Yang, C. Soudais, S. Dupuis, J. Feinberg, C. Fieschi, C. Elbim, R. Hitchcock, D. Lammas, G. Davies, A. Al-Ghonaium, H. Al-Rayes, S. Al-Jumaah, S. Al-Hajjar, I. Z. Al-Mohsen, H. H. Frayha, R. Rucker, T. R. Hawn, A. Aderem, H. Tufenkeji, S. Haraguchi, N. K. Day, R. A. Good, M. A. Gougerot-Pocidalo, A. Ozinsky, J. L. Casanova, Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299, 2076-2079 (2003).
25. H. von Bernuth, C. Picard, Z. Jin, R. Pankla, H. Xiao, C. L. Ku, M. Chrabieh, I. B. Mustapha, P. Ghandil, Y. Camcioglu, J. Vasconcelos, N. Sirvent, M. Guedes, A. B. Vitor, M. J. Herrero-Mata, J. I. Aróstegui, C. Rodrigo, L. Alsina, E. Ruiz-Ortiz, M. Juan, C. Fortuny, J. Yagüe, J. Antón, M. Pascal, H. H. Chang, L. Janniere, Y. Rose, B. Z. Garty, H. Chapel, A. Issekutz, L. Maródi, C. Rodriguez-Gallego, J. Banchereau, L. Abel, X. Li, D. Chaussabel, A. Puel, J. L. Casanova, Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321, 691-696 (2008).
26. L. Alsina, E. Israelsson, M. C. Altman, K. K. Dang, P. Ghandil, L. Israel, H. von Bernuth, N. Baldwin, H. Qin, Z. Jin, R. Banchereau, E. Anguiano, A. Ionan, L. Abel, A. Puel, C. Picard, V. Pascual, J. L. Casanova, D. Chaussabel, A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4. Nat. Immunol. 15, 1134-1142 (2014).
27. C. Parekh, G. M. Crooks, Critical differences in hematopoiesis and lymphoid development between humans and mice. J. Clin. Immunol. 33, 711-715 (2013).
28. A. S. Lauring, J. O. Jones, R. Andino, Rationalizing the development of live attenuated virus vaccines. Nat. Biotechnol. 28, 573-579 (2010).
29. M. Shingai, T. Ebihara, N. A. Begum, A. Kato, T. Honma, K. Matsumoto, H. Saito, H. Ogura, M. Matsumoto, T. Seya, Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus. J. Immunol. 179, 6123-6133 (2007).
30. B. Mrkic, J. Pavlovic, T. Rülicke, P. Volpe, C. J. Buchholz, D. Hourcade, J. P. Atkinson, A. Aguzzi, R. Cattaneo, Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72, 7420-7427 (1998).
31. F. Altare, E. Jouanguy, S. Lamhamedi, R. Döffinger, A. Fischer, J. L. Casanova, Mendelian susceptibility to mycobacterial infection in man. Curr. Opin. Immunol. 10, 413-417 (1998).
32. C. Sommereyns, S. Paul, P. Staeheli, T. Michiels, IFN-lambda (IFN-l) is expressed in a tissuedependent fashion and primarily acts on epithelial cells in vivo. PLOS Pathog. 4, e1000017 (2008).
33. R. C. Gentleman, V. J. Carey, D. M. Bates, B. Bolstad, M. Dettling, S. Dudoit, B. Ellis, L. Gautier, Y. Ge, J. Gentry, K. Hornik, T. Hothorn, W. Huber, S. Iacus, R. Irizarry, F. Leisch, C. Li, M. Maechler, A. J. Rossini, G. Sawitzki, C. Smith, G. Smyth, L. Tierney, J. Y. Yang, J. Zhang, Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).
34. P. Du, W. A. Kibbe, S. M. Lin, lumi: A pipeline for processing Illumina microarray. Bioinformatics 24, 1547-1548 (2008).
35. S. M. Lin, P. Du, W. Huber, W. A. Kibbe, Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res. 36, e11 (2008).